Table 1.

Comparison of clinical features between the 2 groups.

	Total Number (n = 179)	ω-3 PUFAs group (n = 90)	Placebo group (n = 89)	x2	P
Gender				0.005	.943
Male	93 (52.0%)	47 (52.2%)	46 (51.7%)
Female	86 (48.0%)	43 (47.8%)	43 (48.3%)
Age				2.011	.156
<65	85 (47.5%)	38 (42.2%)	47 (52.8%)
≥65	94 (52.5%)	52 (57.8%)	42 (47.2%)
ECOG score				0.137	.712
2	84 (46.9%)	41 (45.6%)	43 (48.3%)
3	95 (53.1%)	49 (54.4%)	46 (51.7%)
Clinical stage				0.148	.700
III	79 (44.1%)	41 (45.6%)	38 (42.7%)
IV	100 (55.9%)	49 (54.4%)	51 (57.3%)
BMI		18.85 ± 1.69	18.77 ± 1.52		.755
Temperature		36.74 ± 0.402	36.77 ± 0.366		.554
Respiratory rates		18.48 ± 2.833	18.38 ± 2.906		.824
Pulse (Times)		77.778 ± 9.24	78.967 ± 8.090		.361
SBP (mm Hg)		116.778 ± 15.020	116.494 ± 13.869		.896
DBP (mm Hg)		77.378 ± 9.069	77.629 ± 8.790		.851

DBP = Diastolic blood pressure, SBP = Systolic blood pressure.